<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title>Candy Swift's tracks</title><link>https://www.spreaker.com/show/candy-swifts-tracks</link><description><![CDATA[]]></description><atom:link href="https://www.spreaker.com/show/1764003/episodes/feed" rel="self" type="application/rss+xml"/><language>en</language><category>Society &amp; Culture</category><copyright>Copyright Candy Swift</copyright><image><url>https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg</url><title>Candy Swift's tracks</title><link>https://www.spreaker.com/show/candy-swifts-tracks</link></image><lastBuildDate>Wed, 16 Aug 2017 07:29:04 +0000</lastBuildDate><itunes:author>Candy Swift</itunes:author><itunes:owner><itunes:name>Candy Swift</itunes:name><itunes:email>feeds@spreaker.com</itunes:email></itunes:owner><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:category text="Society &amp; Culture"/><itunes:explicit>clean</itunes:explicit><itunes:type>episodic</itunes:type><googleplay:author>Candy Swift</googleplay:author><googleplay:email>feeds@spreaker.com</googleplay:email><googleplay:category text="Society &amp; Culture"/><googleplay:explicit>No</googleplay:explicit><item><title>SusanSolomon_2012G</title><link>https://www.spreaker.com/user/biotechworld/susansolomon-2012g</link><description><![CDATA[Although single domain antibodies isolated from antibody libraries derived from gene synthesis and immunized or naïve animals generally exhibit reasonable affinity, it is often desirable to further increase their affinity. Quantitative library sorting by phage display or yeast surface display is used for improving the affinity of single domain antibodies. In particular, we have developed a proprietary DNA mutagenesis technique that is able to create a huge number (e.g. 1010) variants of the parental antibody with defined positions mutated.<br /><br /><a href="http://www.creative-biolabs.com/Nanobody-Affinity-Maturation.html" rel="noopener">http://www.creative-biolabs.com/Nanobody-Affinity-Maturation.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/12585716</guid><pubDate>Wed, 16 Aug 2017 07:29:04 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/12585716/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Although single domain antibodies isolated from antibody libraries derived from gene synthesis and immunized or naïve animals generally exhibit reasonable affinity, it is often desirable to further increase their affinity. Quantitative library sorting...</itunes:subtitle><itunes:summary><![CDATA[Although single domain antibodies isolated from antibody libraries derived from gene synthesis and immunized or naïve animals generally exhibit reasonable affinity, it is often desirable to further increase their affinity. Quantitative library sorting by phage display or yeast surface display is used for improving the affinity of single domain antibodies. In particular, we have developed a proprietary DNA mutagenesis technique that is able to create a huge number (e.g. 1010) variants of the parental antibody with defined positions mutated.<br /><br /><a href="http://www.creative-biolabs.com/Nanobody-Affinity-Maturation.html" rel="noopener">http://www.creative-biolabs.com/Nanobody-Affinity-Maturation.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>biotech,biotechnology</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Although single domain antibodies isolated from antibody libraries derived from gene synthesis and immunized or naïve animals generally exhibit reasonable affinity, it is often desirable to further increase their affinity. Quantitative library sorting by phage display or yeast surface display is used for improving the affinity of single domain antibodies. In particular, we have developed a proprietary DNA mutagenesis technique that is able to create a huge number (e.g. 1010) variants of the parental antibody with defined positions mutated.

http://www.creative-biolabs.com/Nanobody-Affinity-Maturation.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>anti-therapeutic antibodies</title><link>https://www.spreaker.com/user/biotechworld/anti-therapeutic-antibodies</link><description><![CDATA[Therapeutic proteins are proteins that are engineered in the laboratory for pharmaceutical use, including noncovalent binders, proteins that affect covalent bonds which are almost all enzymes, and albumin. Therapeutic proteins are highly effective in vivo and have revolutionized treatment of diseases. Protein therapeutics permits an individualized treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein.<br /><br /><a href="http://www.creativebiolabs.net/therapeutic-proteins_47.htm" rel="noopener">http://www.creativebiolabs.net/therapeutic-proteins_47.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9984359</guid><pubDate>Mon, 28 Nov 2016 03:56:06 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9984359/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Therapeutic proteins are proteins that are engineered in the laboratory for pharmaceutical use, including noncovalent binders, proteins that affect covalent bonds which are almost all enzymes, and albumin. Therapeutic proteins are highly effective in...</itunes:subtitle><itunes:summary><![CDATA[Therapeutic proteins are proteins that are engineered in the laboratory for pharmaceutical use, including noncovalent binders, proteins that affect covalent bonds which are almost all enzymes, and albumin. Therapeutic proteins are highly effective in vivo and have revolutionized treatment of diseases. Protein therapeutics permits an individualized treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein.<br /><br /><a href="http://www.creativebiolabs.net/therapeutic-proteins_47.htm" rel="noopener">http://www.creativebiolabs.net/therapeutic-proteins_47.htm</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:keywords>anti-therapeutic antibodies</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Therapeutic proteins are proteins that are engineered in the laboratory for pharmaceutical use, including noncovalent binders, proteins that affect covalent bonds which are almost all enzymes, and albumin. Therapeutic proteins are highly effective in vivo and have revolutionized treatment of diseases. Protein therapeutics permits an individualized treatment approach by supporting a specifically targeted therapeutic process by compensating the deficiency of an essential protein.

http://www.creativebiolabs.net/therapeutic-proteins_47.htm</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>humanized</title><link>https://www.spreaker.com/user/biotechworld/humanized</link><description><![CDATA[<a href="http://www.creative-biolabs.com/antibody-humanization.html" rel="noopener">http://www.creative-biolabs.com/antibody-humanization.html</a><br /><br />Humanization is important for reducing the immunogenicity of monoclonal antibodies derived from xenogeneic sources (commonly rodent) and for improving their activation of the human immune system. Since the development of the hybridoma technology, a large number of rodent monoclonal antibodies with specificity for antigens of therapeutic interest have been generated and characterized.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9984323</guid><pubDate>Mon, 28 Nov 2016 03:47:29 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9984323/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/antibody-humanization.html

Humanization is important for reducing the immunogenicity of monoclonal antibodies derived from xenogeneic sources (commonly rodent) and for improving their activation of the human immune...</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/antibody-humanization.html" rel="noopener">http://www.creative-biolabs.com/antibody-humanization.html</a><br /><br />Humanization is important for reducing the immunogenicity of monoclonal antibodies derived from xenogeneic sources (commonly rodent) and for improving their activation of the human immune system. Since the development of the hybridoma technology, a large number of rodent monoclonal antibodies with specificity for antigens of therapeutic interest have been generated and characterized.]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/antibody-humanization.html

Humanization is important for reducing the immunogenicity of monoclonal antibodies derived from xenogeneic sources (commonly rodent) and for improving their activation of the human immune system. Since the development of the hybridoma technology, a large number of rodent monoclonal antibodies with specificity for antigens of therapeutic interest have been generated and characterized.</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>display construction</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t_7</link><description><![CDATA[<a href="http://www.creative-biolabs.com/phage-display-library-construction.html" rel="noopener">http://www.creative-biolabs.com/phage-display-library-construction.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762258</guid><pubDate>Mon, 31 Oct 2016 08:04:03 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762258/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/phage-display-library-construction.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/phage-display-library-construction.html" rel="noopener">http://www.creative-biolabs.com/phage-display-library-construction.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>display construction</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/phage-display-library-construction.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>antibody synthesis</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t_6</link><description><![CDATA[<a href="http://www.creative-biolabs.com/Antibody-Production-Services.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Production-Services.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762256</guid><pubDate>Mon, 31 Oct 2016 07:55:41 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762256/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/Antibody-Production-Services.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/Antibody-Production-Services.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Production-Services.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>antibody synthesis</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/Antibody-Production-Services.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>antibody engineering</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t_5</link><description><![CDATA[<a href="http://www.creative-biolabs.com/Antibody-Engineering-Services.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Engineering-Services.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762180</guid><pubDate>Mon, 31 Oct 2016 07:49:51 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762180/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/Antibody-Engineering-Services.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/Antibody-Engineering-Services.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Engineering-Services.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>antibody engineering</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/Antibody-Engineering-Services.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>scfv phage display library</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t_4</link><description><![CDATA[<a href="http://www.creative-biolabs.com/Premade-antibody-and-peptide-Libraries.html" rel="noopener">http://www.creative-biolabs.com/Premade-antibody-and-peptide-Libraries.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762172</guid><pubDate>Mon, 31 Oct 2016 07:49:17 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762172/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/Premade-antibody-and-peptide-Libraries.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/Premade-antibody-and-peptide-Libraries.html" rel="noopener">http://www.creative-biolabs.com/Premade-antibody-and-peptide-Libraries.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>scfv phage display library</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/Premade-antibody-and-peptide-Libraries.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>affinity maturation of antibodies</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t_3</link><description><![CDATA[<a href="http://www.creative-biolabs.com/antibody-affinity-maturation.html" rel="noopener">http://www.creative-biolabs.com/antibody-affinity-maturation.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762170</guid><pubDate>Mon, 31 Oct 2016 07:48:40 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762170/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/antibody-affinity-maturation.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/antibody-affinity-maturation.html" rel="noopener">http://www.creative-biolabs.com/antibody-affinity-maturation.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>affinity maturation of antibod</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/antibody-affinity-maturation.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>single chain antibody library</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t_2</link><description><![CDATA[<a href="http://www.creative-biolabs.com/single-domain-antibody-library-service.html" rel="noopener">http://www.creative-biolabs.com/single-domain-antibody-library-service.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762163</guid><pubDate>Mon, 31 Oct 2016 07:47:57 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762163/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/single-domain-antibody-library-service.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/single-domain-antibody-library-service.html" rel="noopener">http://www.creative-biolabs.com/single-domain-antibody-library-service.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>single chain antibody library</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/single-domain-antibody-library-service.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>antibody sequencing</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t_1</link><description><![CDATA[<a href="http://www.creative-biolabs.com/next-generation-antibody-sequencing.html" rel="noopener">http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762159</guid><pubDate>Mon, 31 Oct 2016 07:46:33 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762159/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/next-generation-antibody-sequencing.html" rel="noopener">http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</a>]]></itunes:summary><itunes:duration>605</itunes:duration><itunes:keywords>antibody sequencing</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>display library</title><link>https://www.spreaker.com/user/biotechworld/ellenjorgensen-2016t</link><description><![CDATA[<a href="http://www.creative-biolabs.com/phage-display-library-screening.html" rel="noopener">http://www.creative-biolabs.com/phage-display-library-screening.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9762146</guid><pubDate>Mon, 31 Oct 2016 07:38:44 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9762146/ellenjorgensen_2016t.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>http://www.creative-biolabs.com/phage-display-library-screening.html</itunes:subtitle><itunes:summary><![CDATA[<a href="http://www.creative-biolabs.com/phage-display-library-screening.html" rel="noopener">http://www.creative-biolabs.com/phage-display-library-screening.html</a>]]></itunes:summary><itunes:duration>604</itunes:duration><itunes:keywords>display library</itunes:keywords><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>http://www.creative-biolabs.com/phage-display-library-screening.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>protein therapeutics</title><link>https://www.spreaker.com/user/biotechworld/protein-therapeutics</link><description><![CDATA[Reference: <a href="http://www.creativebiolabs.net/therapeutic-proteins_47.htm" rel="noopener">http://www.creativebiolabs.net/therapeutic-proteins_47.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9331890</guid><pubDate>Mon, 05 Sep 2016 03:52:54 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9331890/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creativebiolabs.net/therapeutic-proteins_47.htm</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creativebiolabs.net/therapeutic-proteins_47.htm" rel="noopener">http://www.creativebiolabs.net/therapeutic-proteins_47.htm</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creativebiolabs.net/therapeutic-proteins_47.htm</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>antibody drug conjugate</title><link>https://www.spreaker.com/user/biotechworld/antibody-drug-conjugate</link><description><![CDATA[Reference: <a href="http://www.creativebiolabs.net/antibody-drug-conjugates-production.htm" rel="noopener">http://www.creativebiolabs.net/antibody-drug-conjugates-production.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9331888</guid><pubDate>Mon, 05 Sep 2016 03:52:05 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9331888/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creativebiolabs.net/antibody-drug-conjugates-production.htm</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creativebiolabs.net/antibody-drug-conjugates-production.htm" rel="noopener">http://www.creativebiolabs.net/antibody-drug-conjugates-production.htm</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creativebiolabs.net/antibody-drug-conjugates-production.htm</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>bispecific antibodies</title><link>https://www.spreaker.com/user/biotechworld/bispecific-antibodies</link><description><![CDATA[Reference: <a href="http://www.creative-biolabs.com/next-generation-antibody-sequencing.html" rel="noopener">http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9331868</guid><pubDate>Mon, 05 Sep 2016 03:47:23 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9331868/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creative-biolabs.com/next-generation-antibody-sequencing.html" rel="noopener">http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>de novo sequence</title><link>https://www.spreaker.com/user/biotechworld/de-novo-sequence</link><description><![CDATA[Reference: <a href="http://www.creative-biolabs.com/next-generation-antibody-sequencing.html" rel="noopener">http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9331865</guid><pubDate>Mon, 05 Sep 2016 03:46:33 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9331865/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creative-biolabs.com/next-generation-antibody-sequencing.html" rel="noopener">http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creative-biolabs.com/next-generation-antibody-sequencing.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>anti-idiotypic antibodies</title><link>https://www.spreaker.com/user/biotechworld/anti-idiotypic-antibodies</link><description><![CDATA[Reference: <a href="http://www.creativebiolabs.net/Bispecific-Antibodies_12.htm" rel="noopener">http://www.creativebiolabs.net/Bispecific-Antibodies_12.htm</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9331850</guid><pubDate>Mon, 05 Sep 2016 03:40:13 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9331850/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creativebiolabs.net/Bispecific-Antibodies_12.htm</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creativebiolabs.net/Bispecific-Antibodies_12.htm" rel="noopener">http://www.creativebiolabs.net/Bispecific-Antibodies_12.htm</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creativebiolabs.net/Bispecific-Antibodies_12.htm</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>antibody synthesis</title><link>https://www.spreaker.com/user/biotechworld/antibody-synthesis</link><description><![CDATA[Reference: <a href="http://www.creative-biolabs.com/Antibody-Production-Services.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Production-Services.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9331846</guid><pubDate>Mon, 05 Sep 2016 03:38:27 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9331846/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creative-biolabs.com/Antibody-Production-Services.html</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creative-biolabs.com/Antibody-Production-Services.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Production-Services.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creative-biolabs.com/Antibody-Production-Services.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>Antibody Purification</title><link>https://www.spreaker.com/user/biotechworld/antibody-purification</link><description><![CDATA[Reference: <a href="http://www.creative-biolabs.com/Antibody-Protein-Purification-Service.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Protein-Purification-Service.html</a>]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9331798</guid><pubDate>Mon, 05 Sep 2016 03:21:14 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9331798/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creative-biolabs.com/Antibody-Protein-Purification-Service.html</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creative-biolabs.com/Antibody-Protein-Purification-Service.html" rel="noopener">http://www.creative-biolabs.com/Antibody-Protein-Purification-Service.html</a>]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creative-biolabs.com/Antibody-Protein-Purification-Service.html</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>phage display techniques</title><link>https://www.spreaker.com/user/biotechworld/phage-display-techniques</link><description><![CDATA[Reference: <a href="http://www.creative-biolabs.com/phage-display-service.html" rel="noopener">http://www.creative-biolabs.com/phage-display-service.html</a><br /><br />Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9182399</guid><pubDate>Sat, 13 Aug 2016 03:41:54 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9182399/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creative-biolabs.com/phage-display-service.html

Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on...</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creative-biolabs.com/phage-display-service.html" rel="noopener">http://www.creative-biolabs.com/phage-display-service.html</a><br /><br />Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creative-biolabs.com/phage-display-service.html

Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>fab library</title><link>https://www.spreaker.com/user/biotechworld/fab-library</link><description><![CDATA[References: <a href="http://www.creative-biolabs.com/phage-display-service.html" rel="noopener">http://www.creative-biolabs.com/phage-display-service.html</a><br /><br />Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9182388</guid><pubDate>Sat, 13 Aug 2016 03:37:53 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9182388/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>References: http://www.creative-biolabs.com/phage-display-service.html

Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based...</itunes:subtitle><itunes:summary><![CDATA[References: <a href="http://www.creative-biolabs.com/phage-display-service.html" rel="noopener">http://www.creative-biolabs.com/phage-display-service.html</a><br /><br />Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>References: http://www.creative-biolabs.com/phage-display-service.html

Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>phage display protocols</title><link>https://www.spreaker.com/user/biotechworld/phage-display-protocols</link><description><![CDATA[Reference: <a href="http://www.creative-biolabs.com/phage-display-service.html" rel="noopener">http://www.creative-biolabs.com/phage-display-service.html</a><br /><br />Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9182021</guid><pubDate>Sat, 13 Aug 2016 02:13:33 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9182021/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creative-biolabs.com/phage-display-service.html

Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on...</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creative-biolabs.com/phage-display-service.html" rel="noopener">http://www.creative-biolabs.com/phage-display-service.html</a><br /><br />Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creative-biolabs.com/phage-display-service.html

Phage display is one of the most widely used laboratory technique for the study of protein-protein, protein-peptide and protein-DNA interactions. This technology is mainly based on the use of filamentous phage which is a kind of virus lives on Escherichia coli and has been proven as a powerful method to interrogate libraries containing millions or even billions of different peptides or proteins. Theoretically, phage display is an exogenous gene expression method which the gene encoding the interest protein is inserted into bacteriophage coat protein gene then displaying the interest protein on the phage surfaces, resulting in a connection between genotype and phenotype. Through DNA manipulation, numerous gene variants can be created and constructed as phage display library. To detect the interaction between displayed protein and those other molecules, phage display library can be screened to against other proteins, peptides or DNA sequences for selecting specific binders.</googleplay:description><googleplay:explicit>No</googleplay:explicit></item><item><title>peptide phage display</title><link>https://www.spreaker.com/user/biotechworld/peptide-phage-display</link><description><![CDATA[Reference: <a href="http://www.creative-biolabs.com/premade-phage-display-peptide-libraries.html" rel="noopener">http://www.creative-biolabs.com/premade-phage-display-peptide-libraries.html</a><br /><br />TriCo-16™ Phage Display Peptide Library<br />Type: pIII-fusion, True Phage Display<br />Format: 16-mer peptide library<br />Capacity: 2.60×1010<br />Trimer codons technology<br />Avoid stop and non-sense codon<br />Trimer codon for cysteine was excluded<br /><br />TriCo-20™ Phage Display Peptide Library<br />Type: pIII-fusion, True Phage Display<br />Format: 20-mer peptide library<br />Capacity: 1.70×109<br /><br />Trimer codons technology<br />Avoid stop and non-sense codon<br />Trimer codon for cysteine was excluded]]></description><guid isPermaLink="false">https://api.spreaker.com/episode/9181993</guid><pubDate>Sat, 13 Aug 2016 02:06:21 +0000</pubDate><enclosure url="https://api.spreaker.com/download/episode/9181993/susansolomon_2012g.mp3" length="0" type="audio/mpeg"/><itunes:author>Candy Swift</itunes:author><itunes:subtitle>Reference: http://www.creative-biolabs.com/premade-phage-display-peptide-libraries.html

TriCo-16™ Phage Display Peptide Library
Type: pIII-fusion, True Phage Display
Format: 16-mer peptide library
Capacity: 2.60×1010
Trimer codons technology
Avoid...</itunes:subtitle><itunes:summary><![CDATA[Reference: <a href="http://www.creative-biolabs.com/premade-phage-display-peptide-libraries.html" rel="noopener">http://www.creative-biolabs.com/premade-phage-display-peptide-libraries.html</a><br /><br />TriCo-16™ Phage Display Peptide Library<br />Type: pIII-fusion, True Phage Display<br />Format: 16-mer peptide library<br />Capacity: 2.60×1010<br />Trimer codons technology<br />Avoid stop and non-sense codon<br />Trimer codon for cysteine was excluded<br /><br />TriCo-20™ Phage Display Peptide Library<br />Type: pIII-fusion, True Phage Display<br />Format: 20-mer peptide library<br />Capacity: 1.70×109<br /><br />Trimer codons technology<br />Avoid stop and non-sense codon<br />Trimer codon for cysteine was excluded]]></itunes:summary><itunes:duration>911</itunes:duration><itunes:explicit>clean</itunes:explicit><itunes:image href="https://d3wo5wojvuv7l.cloudfront.net/images.spreaker.com/cloudinary/s--nLNR2PXt--/w_1000,h_800,c_fit,l_text:Lato_160_bold:Candy%20Swift%20s%20tracks/images.spreaker.com/default/show-1400x1400-20190801.jpg"/><itunes:episodeType>full</itunes:episodeType><googleplay:author>Candy Swift</googleplay:author><googleplay:description>Reference: http://www.creative-biolabs.com/premade-phage-display-peptide-libraries.html

TriCo-16™ Phage Display Peptide Library
Type: pIII-fusion, True Phage Display
Format: 16-mer peptide library
Capacity: 2.60×1010
Trimer codons technology
Avoid stop and non-sense codon
Trimer codon for cysteine was excluded

TriCo-20™ Phage Display Peptide Library
Type: pIII-fusion, True Phage Display
Format: 20-mer peptide library
Capacity: 1.70×109

Trimer codons technology
Avoid stop and non-sense codon
Trimer codon for cysteine was excluded</googleplay:description><googleplay:explicit>No</googleplay:explicit></item></channel></rss>
